clopidogrel has been researched along with Pulmonary Embolism in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (31.58) | 29.6817 |
2010's | 11 (57.89) | 24.3611 |
2020's | 2 (10.53) | 2.80 |
Authors | Studies |
---|---|
Anil Kumar, KS; Bajaj, K; Barthwal, MK; Dikshit, DK; Dikshit, M; Jain, M; Misra, A; Shandilya, S; Shukla, P; Srivastava, S | 1 |
Anil Kumar, S; Othman, M; Tafazoli, A | 1 |
Brüggemann, R; Gietema, H; Jallah, B; Spaetgens, B; Stehouwer, C; Ten Cate, H | 1 |
Giacomini, T; Prato, G; Rossi, A; Severino, M; Verrina, E | 1 |
de Potter, T; Dujka, L; Jiresova, E; Lekesova, V; Neuzil, P; Reddy, VY; Rensing, B; Tromp, SC; van der Heyden, J | 1 |
Kalinin, AA; Morozov, SP; Nosenko, EM; Patlachuk, MV; Sal'nikov, PS | 1 |
Bramlage, P; Diehm, C; Lawall, H; Oberacker, R; Schellong, SM; Zemmrich, C | 1 |
Bergmeier, W; Boulaftali, Y; Cooley, BC; Dee, R; Fuentes, R; Geddings, JE; Getz, TM; Hisada, Y; Key, NS; Mackman, N; Whelihan, M; Wolberg, AS | 1 |
Baber, U; Dangas, GD; Giustino, G; Guimarães, AH; Hemmrich, M; Mehran, R; Thomitzek, K; Tijssen, J; Valgimigli, M; van Es, GA; Volkl, AA; Vranckx, P; Welsh, RC; Wildgoose, P; Windecker, S; Zazula, A | 1 |
Chae, HJ; Cho, HJ; Chun, S; Ji, M; Kim, IS; Kim, S; Lee, SY; Lee, W; Song, SH; Wee, KA; Woo, HI; Yun, YM | 1 |
Li, Y; Wang, N | 1 |
Gentilomo, C; Huang, YS; Raffini, L | 1 |
Carpio, A; Chae, YK; Gupta, S; Khemasuwan, D; Lucca, AB; Mora, JI; Neagu, S; Valsecchi, ME; Yun, JH | 1 |
Fishbein, MC; Goldhaber, SZ; Sobieszczyk, P | 1 |
Eikelboom, JW; Hankey, GJ | 1 |
Alberti, PF; Del Soldato, P; Gresele, P; Minuz, P; Momi, S; Pitchford, SC | 1 |
Hylands, R | 1 |
Boutary, M; Dorr, LD; Gendelman, V; Long, WT; Maheshwari, AV; Wan, Z | 1 |
Cerbone, AM; Di Minno, G; Tufano, A | 1 |
2 review(s) available for clopidogrel and Pulmonary Embolism
Article | Year |
---|---|
Thrombocytopathy vs Platelet hyper-reactivity in COVID-19: diverse pathologies, disease outcomes and therapeutic implications.
Topics: Abciximab; Acute Disease; Anticoagulants; Aspirin; Blood Platelets; Clopidogrel; COVID-19; COVID-19 Drug Treatment; Cytokine Release Syndrome; Disseminated Intravascular Coagulation; Fibrinolytic Agents; Humans; Lung; Platelet Activation; Pulmonary Embolism; SARS-CoV-2; Treatment Outcome | 2022 |
The use of antithrombotic drugs in older people.
Topics: Aged; Aspirin; Clopidogrel; Fibrinolytic Agents; Heparin; Heparin, Low-Molecular-Weight; Humans; Myocardial Infarction; Platelet Aggregation Inhibitors; Pulmonary Embolism; Secondary Prevention; Stroke; Thromboembolism; Thrombolytic Therapy; Ticlopidine; Venous Thrombosis; Warfarin | 2002 |
2 trial(s) available for clopidogrel and Pulmonary Embolism
Article | Year |
---|---|
Permanent Percutaneous Carotid Artery Filter to Prevent Stroke in Atrial Fibrillation Patients: The CAPTURE Trial.
Topics: Aged; Anticoagulants; Aspirin; Atrial Fibrillation; Carotid Artery, Common; Clopidogrel; Embolic Protection Devices; Female; Fibrinolytic Agents; Heparin; Humans; Injections, Subcutaneous; Male; Platelet Aggregation Inhibitors; Primary Prevention; Prospective Studies; Pulmonary Embolism; Stroke; Thromboembolism; Ultrasonography, Interventional | 2019 |
Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO study.
Topics: Aortic Valve Stenosis; Aspirin; Cardiovascular Diseases; Cause of Death; Clopidogrel; Drug Therapy, Combination; Embolism; Factor Xa Inhibitors; Heart Valve Diseases; Humans; Mortality; Myocardial Infarction; Platelet Aggregation Inhibitors; Postoperative Care; Pulmonary Embolism; Rivaroxaban; Stroke; Thrombosis; Ticlopidine; Transcatheter Aortic Valve Replacement; Venous Thrombosis | 2017 |
15 other study(ies) available for clopidogrel and Pulmonary Embolism
Article | Year |
---|---|
Synthesis and evaluation of dual antiplatelet activity of bispidine derivatives of N-substituted pyroglutamic acids.
Topics: Animals; Blood Coagulation; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Hemorrhage; Humans; Mice; Platelet Adhesiveness; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Pyrrolidonecarboxylic Acid; Thrombosis | 2016 |
Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
Topics: Anticoagulants; Cerebral Infarction; Clopidogrel; Computed Tomography Angiography; Coronavirus Infections; COVID-19; Frontal Lobe; Humans; Male; Middle Aged; Nadroparin; Pandemics; Peripheral Arterial Disease; Pneumonia, Viral; Pulmonary Embolism; Recombinant Proteins; Recurrence; Thrombophilia; Tinzaparin; Tissue Plasminogen Activator | 2020 |
Reversible cerebral vasoconstriction complicating cerebral atherosclerotic vascular disease in Schimke immuno-osseous dysplasia.
Topics: Anticoagulants; Arteriosclerosis; Aspirin; Carvedilol; Child; Clopidogrel; Diagnosis, Differential; Female; Humans; Immunologic Deficiency Syndromes; Intracranial Arteriosclerosis; Magnetic Resonance Angiography; Magnetic Resonance Imaging; Nephrotic Syndrome; Osteochondrodysplasias; Primary Immunodeficiency Diseases; Pulmonary Embolism; Vasoconstriction; Vasodilator Agents | 2018 |
[The staged treatment of popliteal, ileal and femoral arteries aneurisms].
Topics: Aneurysm; Clopidogrel; Combined Modality Therapy; Femoral Artery; Humans; Iliac Artery; Male; Middle Aged; Platelet Aggregation Inhibitors; Popliteal Artery; Popliteal Vein; Pulmonary Embolism; Ticlopidine; Tomography, Spiral Computed; Treatment Outcome; Ultrasonography, Doppler; Vascular Grafting | 2013 |
Prevalence of deep vein thrombosis in acutely admitted ambulatory non-surgical intensive care unit patients.
Topics: Aged; Aged, 80 and over; Anticoagulants; APACHE; Aspirin; Clopidogrel; Female; Fibrin Fibrinogen Degradation Products; Germany; Heparin; Humans; Intensive Care Units; Male; Middle Aged; Outpatient Clinics, Hospital; Patient Admission; Platelet Aggregation Inhibitors; Prevalence; Prospective Studies; Pulmonary Embolism; Risk Factors; Ticlopidine; Venous Thromboembolism; Venous Thrombosis | 2014 |
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
Topics: Adenocarcinoma; Animals; Blood Platelets; Cell Line, Tumor; Cell-Derived Microparticles; Clopidogrel; Female; Flow Cytometry; Humans; Mice; Mice, Inbred C57BL; Neoplasms; Pancreatic Neoplasms; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Thrombin; Thromboplastin; Thrombosis; Ticlopidine | 2016 |
Clinical Pharmacogenetic Testing and Application: Laboratory Medicine Clinical Practice Guidelines.
Topics: Anticoagulants; Antidepressive Agents; Antimetabolites, Antineoplastic; Antitubercular Agents; Arylamine N-Acetyltransferase; Clopidogrel; Coronary Artery Disease; Cytochrome P-450 CYP2C19; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Depressive Disorder; Genotype; Isoniazid; Laboratories, Hospital; Methyltransferases; Pharmacogenomic Testing; Platelet Aggregation Inhibitors; Pulmonary Embolism; Ticlopidine; Tuberculosis; Vitamin K Epoxide Reductases; Warfarin | 2017 |
Antithrombotic effects of Danggui, Honghua and potential drug interaction with clopidogrel.
Topics: Animals; Bleeding Time; Carthamus tinctorius; Clopidogrel; Drug Interactions; Drugs, Chinese Herbal; Male; Pulmonary Embolism; Rats; Rats, Sprague-Dawley; Risk Factors; Thrombosis; Ticlopidine; Venous Thrombosis | 2010 |
Significant increase in clopidogrel use across U.S. children's hospitals.
Topics: Adolescent; Child; Child, Preschool; Clopidogrel; Coronary Thrombosis; Databases, Factual; Drug Therapy, Combination; Female; Heart Defects, Congenital; Hospitals, Pediatric; Humans; Infant; Infant, Newborn; Inpatients; Length of Stay; Male; Mortality; Pediatrics; Platelet Aggregation Inhibitors; Poisson Distribution; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Stroke; Ticlopidine; United States; Venous Thromboembolism | 2011 |
Dose-related effect of statins in venous thrombosis risk reduction.
Topics: Aged; Aspirin; Atherosclerosis; Cerebral Infarction; Clopidogrel; Cohort Studies; Cross-Sectional Studies; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Incidence; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Infarction; Platelet Aggregation Inhibitors; Proportional Hazards Models; Pulmonary Embolism; Retrospective Studies; Risk Reduction Behavior; Ticlopidine; Venous Thromboembolism | 2011 |
Acute pulmonary embolism: don't ignore the platelet.
Topics: Acute Disease; Animals; Anticoagulants; Aspirin; Blood Platelets; Clinical Trials as Topic; Clopidogrel; Disease Models, Animal; Fibrinolytic Agents; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Pulmonary Embolism; Secondary Prevention; Ticlopidine | 2002 |
Antiplatelet drugs.
Topics: Aspirin; Clopidogrel; Dipyridamole; Humans; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Primary Prevention; Pulmonary Embolism; Thrombosis; Ticlopidine; Venous Thrombosis | 2003 |
Nitroaspirin plus clopidogrel versus aspirin plus clopidogrel against platelet thromboembolism and intimal thickening in mice.
Topics: Animals; Aspirin; Blood Coagulation Tests; Clopidogrel; Disease Models, Animal; Drug Therapy, Combination; Hemorrhage; Male; Mice; Mice, Inbred Strains; Platelet Aggregation; Platelet Aggregation Inhibitors; Pulmonary Embolism; Survival Rate; Thromboembolism; Ticlopidine; Tunica Intima | 2005 |
Pulmonary thromboembolism.
Topics: Animals; Cat Diseases; Cats; Clopidogrel; Diagnosis, Differential; Female; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Platelet Aggregation Inhibitors; Pulmonary Embolism; Radiography, Thoracic; Ticlopidine; Tomography, X-Ray Computed; Treatment Outcome | 2006 |
Multimodal thromboprophylaxis for total hip and knee arthroplasty based on risk assessment.
Topics: Adult; Aged; Aged, 80 and over; Anticoagulants; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Aspirin; Clopidogrel; Combined Modality Therapy; Dipyridamole; Early Ambulation; Enoxaparin; Female; Fibrinolytic Agents; Hematologic Agents; Humans; Intermittent Pneumatic Compression Devices; Male; Middle Aged; Platelet Aggregation Inhibitors; Pulmonary Embolism; Retrospective Studies; Risk Assessment; Thromboembolism; Ticlopidine; Venous Thrombosis; Warfarin | 2007 |